Obligation HCA International 7.5% ( US404119AJ84 ) en USD

Société émettrice HCA International
Prix sur le marché refresh price now   112.718 %  ▼ 
Pays  Etas-Unis
Code ISIN  US404119AJ84 ( en USD )
Coupon 7.5% par an ( paiement semestriel )
Echéance 06/11/2033



Prospectus brochure de l'obligation HCA US404119AJ84 en USD 7.5%, échéance 06/11/2033


Montant Minimal 1 000 USD
Montant de l'émission 250 000 000 USD
Cusip 404119AJ8
Notation Standard & Poor's ( S&P ) BBB- ( Qualité moyenne inférieure )
Notation Moody's Baa3 ( Qualité moyenne inférieure )
Prochain Coupon 06/11/2025 ( Dans 111 jours )
Description détaillée HCA, ou analyse en composantes principales hiérarchiques, est une méthode statistique exploratoire qui combine l'analyse en composantes principales (ACP) et une approche hiérarchique pour réduire la dimensionnalité de données complexes et visualiser les relations entre les variables et les observations.

L'Obligation émise par HCA International ( Etas-Unis ) , en USD, avec le code ISIN US404119AJ84, paye un coupon de 7.5% par an.
Le paiement des coupons est semestriel et la maturité de l'Obligation est le 06/11/2033

L'Obligation émise par HCA International ( Etas-Unis ) , en USD, avec le code ISIN US404119AJ84, a été notée Baa3 ( Qualité moyenne inférieure ) par l'agence de notation Moody's.

L'Obligation émise par HCA International ( Etas-Unis ) , en USD, avec le code ISIN US404119AJ84, a été notée BBB- ( Qualité moyenne inférieure ) par l'agence de notation Standard & Poor's ( S&P ).







HCA INC.
424B2 1 g85509b2e424b2.htm HCA INC.
http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (1 of 60)11/5/03 4:42:14 AM


HCA INC.
Table of Contents
Filed Pursuant to Rule 424(b)(2)
Registration No. 333-107536
PROSPECTUS SUPPLEMENT
(To Prospectus dated October 16, 2003)
$600,000,000
HCA Inc.
$350,000,000 5.25% Notes due 2008
$250,000,000 7.50% Notes due 2033
We will pay interest on the notes on May 6 and November 6 of each year, beginning on May 6, 2004. The
2008 notes will mature on November 6, 2008 and will bear interest at a rate of 5.25%. The 2033 notes will
mature on November 6, 2033 and will bear interest at a rate of 7.50%. Interest will accrue from November 6,
2003. We may redeem some or all of the notes of each series at any time at a redemption price described on
page S-12.
Neither the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of the notes or determined if this prospectus supplement or the attached
prospectus is truthful or complete. Any representation to the contrary is a criminal offense.










Proceeds To
Underwriting
Us Before
Price to Public
Discount
Expenses
Per Note Due 2008

99.709%

.600%
99.109%
Total

$348,981,500

$2,100,000

$346,881,500
Per Note Due 2033

99.858%

.875%
98.983%
Total

$249,645,000

$2,187,500

$247,457,500
The notes will not be listed on any securities exchange. Currently, there is no public market for the notes.
We expect to deliver the notes for each series to investors through the book-entry delivery system of The
Depository Trust Company, Clearstream, Luxembourg or Euroclear on or about November 6, 2003.
http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (2 of 60)11/5/03 4:42:14 AM


HCA INC.
Joint Book-Running Managers

Deutsche Bank Securities
Merrill Lynch & Co.
Senior Co-Managers
Banc of America Securities LLC

Citigroup

Mizuho International plc

SunTrust Robinson Humphrey
Co-Managers
BNY Capital Markets, Inc.

Daiwa Securities SMBC Europe

Fleet Securities, Inc.

Scotia Capital
October 31, 2003
http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (3 of 60)11/5/03 4:42:14 AM


HCA INC.
TABLE OF CONTENTS
FORWARD-LOOKING STATEMENTS
PROSPECTUS SUPPLEMENT SUMMARY
RATIO OF EARNINGS TO FIXED CHARGES
USE OF PROCEEDS
CAPITALIZATION
DESCRIPTION OF THE NOTES
UNDERWRITING
http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (4 of 60)11/5/03 4:42:14 AM


HCA INC.
Table of Contents
TABLE OF CONTENTS
Prospectus Supplement



Page
Forward-Looking Statements

S-2
Prospectus Supplement Summary

S-4
Ratio of Earnings to Fixed Charges
S-10
Use of Proceeds
S-10
Capitalization
S-11
Description of the Notes
S-12
Underwriting
S-17
Prospectus


Where You Can Find More Information
3
The Company
4
Ratio of Earnings to Fixed Charges
4
Use of Proceeds
4
Description of the Debt Securities
5
Plan of Distribution
12
Legal Opinions
13
Experts
13
You should read this prospectus supplement along with the attached prospectus. Both documents contain
information that you should consider when making your investment decision. You should rely only on the
information contained or incorporated by reference in this prospectus supplement and the attached prospectus.
We have not, and the underwriters have not, authorized any other person to provide you with different
information. If anyone provides you with different or inconsistent information, you should not rely on it. We are
not, and the underwriters are not, making an offer to sell these securities in any jurisdiction where the offer or
sale is not permitted. You should assume that the information appearing in this prospectus supplement and the
attached prospectus is accurate as of the date on the front cover of this prospectus supplement only. Our business,
financial position, results of operations and prospects may have changed since that date.
S-1
http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (5 of 60)11/5/03 4:42:14 AM


HCA INC.
http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (6 of 60)11/5/03 4:42:14 AM


HCA INC.
Table of Contents
FORWARD-LOOKING STATEMENTS
This prospectus supplement and the attached prospectus include certain disclosures which contain
"forward-looking statements." Forward-looking statements include all statements that do not relate solely to
historical or current facts, and can be identified by the use of words such as "may," "believe," "will," "expect,"
"project," "estimate," "anticipate," "plan," "initiative," or "continue." These forward-looking statements address,
among other things, strategic objectives and the anticipated effects of the offering. See "Prospectus Supplement
Summary." These forward-looking statements are based on our current plans and expectations and are subject to
a number of known and unknown uncertainties and risks, many of which are beyond our control, that could
significantly affect current plans and expectations and our future financial position and results of operations.
These factors include, but are not limited to,

· the highly competitive nature of the health care business,


· the efforts of insurers, health care providers and others to contain health care costs,


· possible changes in the Medicare and Medicaid programs (including outlier programs) that may impact
reimbursements to health care providers and insurers,


· the ability to achieve operating and financial targets, achieve expected levels of patient volumes and
control the costs of providing services,


· the possible enactment of Federal or state health care reform,


· the ability to attract and retain qualified management and personnel, including affiliated physicians,
nurses and medical support personnel,


· potential liabilities and other claims that may be asserted against us,


· fluctuations in the market value of our common stock,


· the ability to complete and the impact of our share repurchase program,


· changes in accounting practices,


· changes in general economic conditions, including growing numbers of uninsured and unemployed
patients,


· future divestitures which may result in additional charges,

http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (7 of 60)11/5/03 4:42:14 AM


HCA INC.

· changes in revenue mix and the ability to enter into and renew managed care provider arrangements on
acceptable terms,


· the availability and terms of capital to fund the expansion of our business,


· changes in business strategy or development plans,


· delays in receiving payment for services provided,


· increases in the amount and risk of collectability of uninsured accounts and deductibles and co-pay
amounts for insured accounts,


· the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions,


· the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws,
regulations, policies and procedures and our corporate integrity agreement with the government,


· changes in Federal, state or local regulations affecting the health care industry,


· the impact of charity care and self-pay discounting policy changes,


· the ability to successfully integrate the operations of Health Midwest and fund expected capital
improvements,


· the ability to develop and implement the financial enterprise resource planning information system
within the expected time and cost projections and, upon implementation, to realize the expected benefits
and efficiencies,
S-2
http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (8 of 60)11/5/03 4:42:14 AM


HCA INC.
Table of Contents

· the ability to enter into definitive written agreements with attorneys representing the class in class action
securities lawsuits originally filed in 1997 against us and with our insurance carriers, and obtain court
approval thereof, and


· other risk factors described in this prospectus supplement, the attached prospectus or the documents
incorporated by reference in this prospectus supplement and the attached prospectus.
As a consequence, current plans, anticipated actions and future financial position and results of operations
may differ from those expressed in any forward-looking statements we make. You should not unduly rely on
these forward-looking statements when evaluating the information presented in this prospectus supplement, the
attached prospectus or the documents incorporated by reference in this prospectus supplement and the attached
prospectus.
S-3
http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (9 of 60)11/5/03 4:42:14 AM


HCA INC.
Table of Contents
PROSPECTUS SUPPLEMENT SUMMARY
You should read the following summary information together with the detailed information included
in this prospectus supplement, the attached prospectus and the documents incorporated by reference in this
prospectus supplement and the attached prospectus. As used in this prospectus supplement and the attached
prospectus, the terms "HCA," "Company," "we," "us" and "our" refer to HCA Inc. and its affiliates. The
term "affiliates" includes our direct and indirect subsidiaries and partnerships and joint ventures in which
our subsidiaries are partners.
HCA
Overview
HCA is a holding company whose affiliates own and operate hospitals and other related health care
entities. At September 30, 2003, our affiliates owned and operated 183 hospitals and 78 freestanding surgery
centers. Our affiliates are also partners in 50/50 joint ventures that own and operate seven hospitals and four
freestanding surgery centers, which are accounted for using the equity method. Our facilities are located in
23 states, England and Switzerland.
Our hospitals provide a comprehensive array of services including internal medicine, cardiology,
oncology, obstetrics, general surgery, neurosurgery and orthopedics, as well as diagnostic and emergency
services. We also provide outpatient and ancillary services through our acute care hospitals and outpatient
facilities, including freestanding surgery and diagnostic centers, rehabilitation and other facilities.
Our Business Strategy
Our business strategy is to be a comprehensive provider of quality health care services in the most
cost-effective manner and consistent with our ethics and compliance program, applicable government
regulations and guidelines and industry standards. We also seek to enhance financial performance by
increasing utilization of our facilities and improving operating efficiencies. To achieve these objectives, we
pursue the following strategies:

· emphasize a "patients first" philosophy;


· emphasize a commitment to ethics and compliance;


· focus on strong assets and invest capital in select, core communities;

http://www.sec.gov/Archives/edgar/data/860730/000095014403012239/g85509b2e424b2.htm (10 of 60)11/5/03 4:42:14 AM


Document Outline